Use of interferon-beta in the treatment of multiple sclerosis.
Derwenskus
Joy
J
Department of Neurology, Northwestern University, Chicago, Illinois, USA.
Lublin
Fred D
FD
D000906:Antibodies / Q000187:drug effects / Q000276:immunology; D002490:Central Nervous System / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use*; D016899:Interferon-beta / Q000009:adverse effects / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology* / Q000503:physiopathology; D055502:Secondary Prevention; D016896:Treatment Outcome
D000906:Antibodies; D007155:Immunologic Factors; D016899:Interferon-beta